A Study of TAK-102 in Adult With Previously-Treated Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Takeda
Related studies linked through entity extraction aliases.
A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy of Vedolizumab in Crohn's Disease Patients Naive to Biological Therapy
- Status
- UNKNOWN
- Phase
- N/A
ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice
- Status
- WITHDRAWN
- Phase
- N/A
A Study of TAK-071 in People With Parkinson Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Ninlaro in Real World Clinical Practice in China
- Status
- COMPLETED
- Phase
- N/A
Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Dexlansoprazole Modified Release (MR) in Gastroesophageal Reflux Disease (GERD) Participants in the Russian Federation
- Status
- WITHDRAWN
- Phase
- N/A
Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease"
- Status
- COMPLETED
- Phase
- N/A
A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of MLN9708 in Japanese Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study to Assess Absolute Bioavailability (ABA) of TAK-831 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]TAK-831 in Male Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"
- Status
- COMPLETED
- Phase
- N/A
A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safest Dose Range for FEIBA in Hemophilia A Patients With Inhibitors on Emicizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4